Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)

China · Delayed Price · Currency is CNY

11.56

-0.27 (-2.28%)

Jun 18, 2026, 3:00 PM CST

-26.37% (1Y)

Market Cap	3.54B -28.6%
Revenue (ttm)	4.56B +52.5%
Net Income	141.43M -47.5%
EPS	0.46 -36.0%
Shares Out	299.43M
PE Ratio	25.73
Forward PE	n/a
Dividend	0.50 (4.23%)
Ex-Dividend Date	Jun 17, 2026

Volume	6,627,850
Open	11.80
Previous Close	11.83
Day's Range	11.54 - 11.82
52-Week Range	11.55 - 20.20
Beta	0.68
Analysts	Strong Buy
Price Target	20.00 (+73.01%)
Earnings Date	Aug 21, 2026

About SHA:605077

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. It offers polyols products such as xylitol, is a polyol that occurs naturally regular sugar raise blood sugar levels; sorbitol, is produced by the catalytic hydrogenation of D-glucose and is available as a free-flowing crystalline powder, and as aqueous solutions; maltitol a bulk sweetener produced from naturally occurring compounds in corn; erythritol, is produced by the enzymatic hydrolysis of starch into glucose, non... [Read more]

Industry Chemicals

Sector Materials

Founded 2001

Employees 2,248

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 605077

Full Company Profile

Financial Performance

In 2025, SHA:605077's revenue was 4.19 billion, an increase of 49.15% compared to the previous year's 2.81 billion. Earnings were 200.30 million, a decrease of -25.40%.

Financial Statements